GlassScriptPhysician profile
Matthew Oglesbee
NPI 1366861528
$2,375.34
in general payments reported to CMS, 2019-2025
16 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $59.74 · 2021: $323 · 2022: $382 · 2023: $429 · 2024: $559 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,319.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $569.99 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $308.32 | 2019-2024 | |
| Gilead Sciences, INC. | $264.83 | 2021-2025 | Veklury |
| Janssen Pharmaceuticals, INC | $223.19 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $139.05 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $138.81 | 2022-2024 | Ultomiris, Soliris |
| Paratek Pharmaceuticals, INC. | $134.86 | 2025 | Nuzyra |
| E.R. Squibb & Sons, L.L.C. | $118.24 | 2019-2022 | |
| Cardiovascular Systems INC. | $102.44 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $102.26 | 2019-2024 | Lifevest |
| Abbvie INC. | $71.33 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $57.86 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $54.39 | 2024-2025 | Terlivaz |
| Inari Medical, INC. | $40.42 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Breas Medical, INC. | $26.96 | 2024 | Vivo 45 Ls |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Oglesbee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.